Merck, known as MSD outside of the United States and Canada, announced the European Commission (EC) has approved Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with Padcev ...

Future Health, a global initiative by Abu Dhabi and Bridge for Billions will launch a new entrepreneurship programme designed to strengthen promising health ventures in emerging markets and help ...

Karnataka govt will address the issue of exorbitant billing by hospitals: minister: Our Bureau, Bengaluru Friday, October 23, 2026, 12:30 Hrs [IST] The Karnataka government will d ...

Appasamy Associates, a Warburg Pincus-backed global surgical ophthalmology manufacturer headquartered in Chennai, India, announced the acquisition of RUCK, a German manufacturer of ophthalmic surgical ...

Amneal Pharmaceuticals, Inc. a US-based global biopharmaceutical company, today, inaugurated its new administrative office in Ahmedabad, supporting its teams in India and strengthening collaboration ...

GE HealthCare announces five new global clinical collaborations to advance the next generation of theranostics imaging: Chicago Friday, October 23, 2026, 12:00 Hrs [IST] GE Health ...

Zylidac Bio partners with Prolific Machines to scale Prolific’s Next-Generation biologics manufacturing platform: Our Bureau, Mumbai Friday, October 23, 2026, 12:40 Hrs [IST] Zy ...

The Central Drugs Standard Control Organisation (CDSCO) has announced a total of 330 drug samples tested across the country during the month of September, 2026, as Not of Standard Quality (NSQ). Out ...

Johnson & Johnson introduces next-generation Shockwav C2 Aero Fly Coronary IVL Catheter to treat broad range of calcified coronary artery lesions: Santa Clara, California Friday, ...

GSK plc announced that the US Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B (CHB) virus infection in combination with nucleos(t)ide ...

Merck partners with NVIDIA, Microsoft & Dawn Health to develop innovative model for PSPs for patients with rare tumours: Darmstadt, Germany Friday, October 23, 2026, 09:00 Hrs [IS ...

It will be important to monitor impact of NPPA’s TMR of 137 anti-cancer medicines on patient access: Anil Matai: Shardul Nautiyal, Mumbai Friday, October 23, 2026, 08:00 Hrs [IS ...